Trials / Completed
CompletedNCT02749994
A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 396 (actual)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A phase Ⅲ, multi-center, randomized, double-blinded, active comparator, factorial design clinical trial to compare the efficacy and safety of a combination therapy of ezetimibe and rosuvastatin versus monotherapy of rosuvastatin in hypercholesterolemia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | |
| DRUG | Ezetimibe |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-04-25
- Last updated
- 2018-06-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02749994. Inclusion in this directory is not an endorsement.